MDNA Life Sciences
MDNA Life Sciences is a privately held biotechnology company founded in 2014 and based in West Palm Beach, Florida, operating with a 1-10 employee team. The company maintains scientific, business, and data leadership functions, though its specific products, pipeline, and commercialization stage are not publicly disclosed.
- Company typePrivate
- Founded2014
- HeadquartersWest Palm Beach, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What MDNA Life Sciences does
MDNA Life Sciences is a privately held biotechnology company founded in 2014 and headquartered in West Palm Beach, Florida. The company operates with a lean team of 1-10 employees and maintains a functional executive structure comprising a CEO, CFO, Chief Scientific Officer, Chief Business Officer, and Chief Data Officer, suggesting it is organized to pursue scientific research and development activities in the life sciences domain.
The firm's specific product portfolio, underlying technology platform, scientific pipeline, and intellectual property base are not disclosed in the available data. The company's public website currently renders only a verification/loading interface rather than substantive company information, and no patents, publications, partnerships, regulatory milestones, or product launches are documented. The presence of a CSO indicates active scientific direction, while the CDO role signals some emphasis on data-related capabilities, though specific applications are not described.
With no disclosed customers, pricing model, revenue figures, funding history, or commercialization milestones in the supplied material, MDNA Life Sciences appears to be at an early or pre-commercial stage. Its business model, target indications, go-to-market strategy, and revenue mechanics cannot be characterized from the evidence available, which is a material limitation for any analytical assessment.
MDNA Life Sciences firmographics
Firmographics- Name
- MDNA Life Sciences
- Website
- https://mdnalifesciences.com
- Company type
- Private
- Founded year
- 2014
- Headcount range
- 1–10 employees
- Short description
- MDNA Life Sciences is a privately held biotechnology company founded in 2014 and based in West Palm Beach, Florida, operating with a 1-10 employee team. The company maintains scientific, business, and data leadership functions, though its specific products, pipeline, and commercialization stage are not publicly disclosed.
- Ownership category
- akta.pro rank
MDNA Life Sciences industry classification
Industry- Product category
- Molecular Diagnostics and Biomarker Discovery
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical Laboratories (621511), Scientific Research and Development Services (5417)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)
- akta.pro secondary industry
- Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)
Keywords
Where MDNA Life Sciences is headquartered
LocationHeadquarters
- HQ city
- West Palm Beach
- HQ country
- United States
- HQ region
- North America
Markets served
MDNA Life Sciences business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
MDNA Life Sciences product offering
Product offeringCore offering
MDNA Life Sciences is a biotechnology company developing molecular diagnostic products and biomarker discovery services centered on mitochondrial DNA (mtDNA) analysis. The firm applies proprietary genetic and molecular biology techniques to identify mtDNA-based biomarkers for disease detection and research applications, serving life sciences research and clinical diagnostic markets.
Differentiator
Problem solved
Functional benefit
Products and services
- Mitochondrial DNA Biomarker Discovery Services Research services that identify and validate mitochondrial DNA-based biomarkers for disease detection, intended for biotechnology, pharmaceutical, and academic research buyers requiring specialized mtDNA analysis.
- Molecular Diagnostic Assay Development Custom and proprietary development of molecular diagnostic assays based on mitochondrial DNA biomarkers, designed for research use and downstream clinical diagnostic applications.
Companies that use MDNA Life Sciences
Customer profileIdeal customer profiles1 record
MDNA Life Sciences technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
MDNA Life Sciences competitors and assessment
Company assessmentBroad incumbents
- Myriad Genetics: Myriad is a major molecular diagnostics company offering germline and somatic genetic tests across oncology, women's health, and mental health. It is a relevant incumbent benchmark for any small molecular DNA-focused biotech like MDNA.
- Guardant Health: Guardant Health is a leading precision oncology liquid biopsy company using circulating tumor DNA for therapy selection and monitoring. Comparable as a molecular DNA diagnostics peer with established clinical and biopharma channels.
- Foundation Medicine: Foundation Medicine (a Roche subsidiary) provides comprehensive genomic profiling of tumors using DNA sequencing to inform oncology treatment. Relevant incumbent comparator for a molecular DNA-based diagnostics company.
- Invitae: Invitae is a genetics company offering genetic testing across multiple disease areas, now operating under Chapter 11 with restructured scope. Relevant as a historical molecular DNA diagnostics comparator despite current distress.
- Exact Sciences: Exact Sciences is a major molecular diagnostics company best known for Cologuard, now expanding into multi-cancer detection and oncology. Relevant broad incumbent comparator for any molecular DNA diagnostics business.
Direct peers
- Natera: Natera is a DNA-based diagnostics company specializing in cell-free DNA testing across reproductive health, oncology, and organ transplant monitoring. Closely comparable to MDNA given the molecular DNA focus and clinical diagnostic positioning.
- NeoGenomics: NeoGenomics operates oncology-focused clinical laboratories providing molecular and genetic testing services to hospitals, oncologists, and researchers. Comparable as a direct molecular diagnostics services peer.
- Veracyte: Veracyte is a genomic diagnostics company developing tests that resolve diagnostic ambiguity in cancer and other diseases using RNA and DNA-based methods. Direct comparator in genomic clinical diagnostics.
Emerging players
- Personalis: Personalis is a smaller molecular diagnostics company focused on immuno-oncology and tumor molecular profiling. Comparable as a peer-scale molecular DNA diagnostics player with biopharma services revenue.
- Caris Life Sciences: Caris provides molecular profiling services including DNA and RNA sequencing for oncology and biopharma partners. Comparable as a mid-sized molecular profiling peer with services + biopharma channel model.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks4 records
Key highlights4 records
Customer concentration
MDNA Life Sciences social profiles
Digital presenceMDNA Life Sciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
MDNA Life Sciences leadership team
Management profileNumber of profiles
Profiles5 records
MDNA Life Sciences funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MDNA Life Sciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MDNA Life Sciences
What does MDNA Life Sciences do?
MDNA Life Sciences is a biotechnology company developing molecular diagnostic products and biomarker discovery services centered on mitochondrial DNA (mtDNA) analysis. The firm applies proprietary genetic and molecular biology techniques to identify mtDNA-based biomarkers for disease detection and research applications, serving life sciences research and clinical diagnostic markets.
When was MDNA Life Sciences founded?
MDNA Life Sciences was founded in 2014. It employs 1 to 10 people.
Where is MDNA Life Sciences based?
MDNA Life Sciences is headquartered in West Palm Beach, United States, in the North America region.
Who are MDNA Life Sciences's main competitors?
Broad incumbents on record are Myriad Genetics, Guardant Health, Foundation Medicine, Invitae and Exact Sciences. Direct peers are Natera, NeoGenomics and Veracyte. Emerging players are Personalis and Caris Life Sciences.
Does MDNA Life Sciences have an API?
No public API is recorded for MDNA Life Sciences.
What industry is MDNA Life Sciences in?
MDNA Life Sciences's product category is Molecular Diagnostics and Biomarker Discovery. Its primary akta.pro industry code is HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics), with a secondary code of HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D). Its NAICS code is 541714 and its SIC code is 2835.